Global SARS-Cov-2 Vaccine (Vero Cell) Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
SARS-Cov-2 Vaccine (Vero Cell) is an immune product made to prevent and control the occurrence and prevalence of infectious diseases caused by the new coronavirus
LPI (LP Information)' newest research report, the “SARS-Cov-2 Vaccine (Vero Cell) Industry Forecast” looks at past sales and reviews total world SARS-Cov-2 Vaccine (Vero Cell) sales in 2022, providing a comprehensive analysis by region and market sector of projected SARS-Cov-2 Vaccine (Vero Cell) sales for 2023 through 2029. With SARS-Cov-2 Vaccine (Vero Cell) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world SARS-Cov-2 Vaccine (Vero Cell) industry.
This Insight Report provides a comprehensive analysis of the global SARS-Cov-2 Vaccine (Vero Cell) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on SARS-Cov-2 Vaccine (Vero Cell) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global SARS-Cov-2 Vaccine (Vero Cell) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for SARS-Cov-2 Vaccine (Vero Cell) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global SARS-Cov-2 Vaccine (Vero Cell).
The global SARS-Cov-2 Vaccine (Vero Cell) market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for SARS-Cov-2 Vaccine (Vero Cell) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for SARS-Cov-2 Vaccine (Vero Cell) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for SARS-Cov-2 Vaccine (Vero Cell) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key SARS-Cov-2 Vaccine (Vero Cell) players cover Sinopharm, Sinovac Biotech, BIBP, IMBCAMS,China and WIBP, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of SARS-Cov-2 Vaccine (Vero Cell) market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global SARS-Cov-2 Vaccine (Vero Cell) market?
What factors are driving SARS-Cov-2 Vaccine (Vero Cell) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do SARS-Cov-2 Vaccine (Vero Cell) market opportunities vary by end market size?
How does SARS-Cov-2 Vaccine (Vero Cell) break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
SARS-Cov-2 Vaccine (Vero Cell) is an immune product made to prevent and control the occurrence and prevalence of infectious diseases caused by the new coronavirus
LPI (LP Information)' newest research report, the “SARS-Cov-2 Vaccine (Vero Cell) Industry Forecast” looks at past sales and reviews total world SARS-Cov-2 Vaccine (Vero Cell) sales in 2022, providing a comprehensive analysis by region and market sector of projected SARS-Cov-2 Vaccine (Vero Cell) sales for 2023 through 2029. With SARS-Cov-2 Vaccine (Vero Cell) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world SARS-Cov-2 Vaccine (Vero Cell) industry.
This Insight Report provides a comprehensive analysis of the global SARS-Cov-2 Vaccine (Vero Cell) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on SARS-Cov-2 Vaccine (Vero Cell) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global SARS-Cov-2 Vaccine (Vero Cell) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for SARS-Cov-2 Vaccine (Vero Cell) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global SARS-Cov-2 Vaccine (Vero Cell).
The global SARS-Cov-2 Vaccine (Vero Cell) market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for SARS-Cov-2 Vaccine (Vero Cell) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for SARS-Cov-2 Vaccine (Vero Cell) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for SARS-Cov-2 Vaccine (Vero Cell) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key SARS-Cov-2 Vaccine (Vero Cell) players cover Sinopharm, Sinovac Biotech, BIBP, IMBCAMS,China and WIBP, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of SARS-Cov-2 Vaccine (Vero Cell) market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Whole Virus Inactivated Vaccine
- Split Vaccine
- Subunit Vaccine
- Others
- Special Population
- General Population
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Sinopharm
- Sinovac Biotech
- BIBP
- IMBCAMS,China
- WIBP
What is the 10-year outlook for the global SARS-Cov-2 Vaccine (Vero Cell) market?
What factors are driving SARS-Cov-2 Vaccine (Vero Cell) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do SARS-Cov-2 Vaccine (Vero Cell) market opportunities vary by end market size?
How does SARS-Cov-2 Vaccine (Vero Cell) break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global SARS-Cov-2 Vaccine (Vero Cell) Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for SARS-Cov-2 Vaccine (Vero Cell) by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for SARS-Cov-2 Vaccine (Vero Cell) by Country/Region, 2018, 2022 & 2029
2.2 SARS-Cov-2 Vaccine (Vero Cell) Segment by Type
2.2.1 Whole Virus Inactivated Vaccine
2.2.2 Split Vaccine
2.2.3 Subunit Vaccine
2.2.4 Others
2.3 SARS-Cov-2 Vaccine (Vero Cell) Sales by Type
2.3.1 Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Type (2018-2023)
2.3.2 Global SARS-Cov-2 Vaccine (Vero Cell) Revenue and Market Share by Type (2018-2023)
2.3.3 Global SARS-Cov-2 Vaccine (Vero Cell) Sale Price by Type (2018-2023)
2.4 SARS-Cov-2 Vaccine (Vero Cell) Segment by Application
2.4.1 Special Population
2.4.2 General Population
2.5 SARS-Cov-2 Vaccine (Vero Cell) Sales by Application
2.5.1 Global SARS-Cov-2 Vaccine (Vero Cell) Sale Market Share by Application (2018-2023)
2.5.2 Global SARS-Cov-2 Vaccine (Vero Cell) Revenue and Market Share by Application (2018-2023)
2.5.3 Global SARS-Cov-2 Vaccine (Vero Cell) Sale Price by Application (2018-2023)
3 GLOBAL SARS-COV-2 VACCINE (VERO CELL) BY COMPANY
3.1 Global SARS-Cov-2 Vaccine (Vero Cell) Breakdown Data by Company
3.1.1 Global SARS-Cov-2 Vaccine (Vero Cell) Annual Sales by Company (2018-2023)
3.1.2 Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Company (2018-2023)
3.2 Global SARS-Cov-2 Vaccine (Vero Cell) Annual Revenue by Company (2018-2023)
3.2.1 Global SARS-Cov-2 Vaccine (Vero Cell) Revenue by Company (2018-2023)
3.2.2 Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Company (2018-2023)
3.3 Global SARS-Cov-2 Vaccine (Vero Cell) Sale Price by Company
3.4 Key Manufacturers SARS-Cov-2 Vaccine (Vero Cell) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers SARS-Cov-2 Vaccine (Vero Cell) Product Location Distribution
3.4.2 Players SARS-Cov-2 Vaccine (Vero Cell) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR SARS-COV-2 VACCINE (VERO CELL) BY GEOGRAPHIC REGION
4.1 World Historic SARS-Cov-2 Vaccine (Vero Cell) Market Size by Geographic Region (2018-2023)
4.1.1 Global SARS-Cov-2 Vaccine (Vero Cell) Annual Sales by Geographic Region (2018-2023)
4.1.2 Global SARS-Cov-2 Vaccine (Vero Cell) Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic SARS-Cov-2 Vaccine (Vero Cell) Market Size by Country/Region (2018-2023)
4.2.1 Global SARS-Cov-2 Vaccine (Vero Cell) Annual Sales by Country/Region (2018-2023)
4.2.2 Global SARS-Cov-2 Vaccine (Vero Cell) Annual Revenue by Country/Region (2018-2023)
4.3 Americas SARS-Cov-2 Vaccine (Vero Cell) Sales Growth
4.4 APAC SARS-Cov-2 Vaccine (Vero Cell) Sales Growth
4.5 Europe SARS-Cov-2 Vaccine (Vero Cell) Sales Growth
4.6 Middle East & Africa SARS-Cov-2 Vaccine (Vero Cell) Sales Growth
5 AMERICAS
5.1 Americas SARS-Cov-2 Vaccine (Vero Cell) Sales by Country
5.1.1 Americas SARS-Cov-2 Vaccine (Vero Cell) Sales by Country (2018-2023)
5.1.2 Americas SARS-Cov-2 Vaccine (Vero Cell) Revenue by Country (2018-2023)
5.2 Americas SARS-Cov-2 Vaccine (Vero Cell) Sales by Type
5.3 Americas SARS-Cov-2 Vaccine (Vero Cell) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC SARS-Cov-2 Vaccine (Vero Cell) Sales by Region
6.1.1 APAC SARS-Cov-2 Vaccine (Vero Cell) Sales by Region (2018-2023)
6.1.2 APAC SARS-Cov-2 Vaccine (Vero Cell) Revenue by Region (2018-2023)
6.2 APAC SARS-Cov-2 Vaccine (Vero Cell) Sales by Type
6.3 APAC SARS-Cov-2 Vaccine (Vero Cell) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe SARS-Cov-2 Vaccine (Vero Cell) by Country
7.1.1 Europe SARS-Cov-2 Vaccine (Vero Cell) Sales by Country (2018-2023)
7.1.2 Europe SARS-Cov-2 Vaccine (Vero Cell) Revenue by Country (2018-2023)
7.2 Europe SARS-Cov-2 Vaccine (Vero Cell) Sales by Type
7.3 Europe SARS-Cov-2 Vaccine (Vero Cell) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa SARS-Cov-2 Vaccine (Vero Cell) by Country
8.1.1 Middle East & Africa SARS-Cov-2 Vaccine (Vero Cell) Sales by Country (2018-2023)
8.1.2 Middle East & Africa SARS-Cov-2 Vaccine (Vero Cell) Revenue by Country (2018-2023)
8.2 Middle East & Africa SARS-Cov-2 Vaccine (Vero Cell) Sales by Type
8.3 Middle East & Africa SARS-Cov-2 Vaccine (Vero Cell) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of SARS-Cov-2 Vaccine (Vero Cell)
10.3 Manufacturing Process Analysis of SARS-Cov-2 Vaccine (Vero Cell)
10.4 Industry Chain Structure of SARS-Cov-2 Vaccine (Vero Cell)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 SARS-Cov-2 Vaccine (Vero Cell) Distributors
11.3 SARS-Cov-2 Vaccine (Vero Cell) Customer
12 WORLD FORECAST REVIEW FOR SARS-COV-2 VACCINE (VERO CELL) BY GEOGRAPHIC REGION
12.1 Global SARS-Cov-2 Vaccine (Vero Cell) Market Size Forecast by Region
12.1.1 Global SARS-Cov-2 Vaccine (Vero Cell) Forecast by Region (2024-2029)
12.1.2 Global SARS-Cov-2 Vaccine (Vero Cell) Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global SARS-Cov-2 Vaccine (Vero Cell) Forecast by Type
12.7 Global SARS-Cov-2 Vaccine (Vero Cell) Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Sinopharm
13.1.1 Sinopharm Company Information
13.1.2 Sinopharm SARS-Cov-2 Vaccine (Vero Cell) Product Portfolios and Specifications
13.1.3 Sinopharm SARS-Cov-2 Vaccine (Vero Cell) Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Sinopharm Main Business Overview
13.1.5 Sinopharm Latest Developments
13.2 Sinovac Biotech
13.2.1 Sinovac Biotech Company Information
13.2.2 Sinovac Biotech SARS-Cov-2 Vaccine (Vero Cell) Product Portfolios and Specifications
13.2.3 Sinovac Biotech SARS-Cov-2 Vaccine (Vero Cell) Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Sinovac Biotech Main Business Overview
13.2.5 Sinovac Biotech Latest Developments
13.3 BIBP
13.3.1 BIBP Company Information
13.3.2 BIBP SARS-Cov-2 Vaccine (Vero Cell) Product Portfolios and Specifications
13.3.3 BIBP SARS-Cov-2 Vaccine (Vero Cell) Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 BIBP Main Business Overview
13.3.5 BIBP Latest Developments
13.4 IMBCAMS,China
13.4.1 IMBCAMS,China Company Information
13.4.2 IMBCAMS,China SARS-Cov-2 Vaccine (Vero Cell) Product Portfolios and Specifications
13.4.3 IMBCAMS,China SARS-Cov-2 Vaccine (Vero Cell) Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 IMBCAMS,China Main Business Overview
13.4.5 IMBCAMS,China Latest Developments
13.5 WIBP
13.5.1 WIBP Company Information
13.5.2 WIBP SARS-Cov-2 Vaccine (Vero Cell) Product Portfolios and Specifications
13.5.3 WIBP SARS-Cov-2 Vaccine (Vero Cell) Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 WIBP Main Business Overview
13.5.5 WIBP Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global SARS-Cov-2 Vaccine (Vero Cell) Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for SARS-Cov-2 Vaccine (Vero Cell) by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for SARS-Cov-2 Vaccine (Vero Cell) by Country/Region, 2018, 2022 & 2029
2.2 SARS-Cov-2 Vaccine (Vero Cell) Segment by Type
2.2.1 Whole Virus Inactivated Vaccine
2.2.2 Split Vaccine
2.2.3 Subunit Vaccine
2.2.4 Others
2.3 SARS-Cov-2 Vaccine (Vero Cell) Sales by Type
2.3.1 Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Type (2018-2023)
2.3.2 Global SARS-Cov-2 Vaccine (Vero Cell) Revenue and Market Share by Type (2018-2023)
2.3.3 Global SARS-Cov-2 Vaccine (Vero Cell) Sale Price by Type (2018-2023)
2.4 SARS-Cov-2 Vaccine (Vero Cell) Segment by Application
2.4.1 Special Population
2.4.2 General Population
2.5 SARS-Cov-2 Vaccine (Vero Cell) Sales by Application
2.5.1 Global SARS-Cov-2 Vaccine (Vero Cell) Sale Market Share by Application (2018-2023)
2.5.2 Global SARS-Cov-2 Vaccine (Vero Cell) Revenue and Market Share by Application (2018-2023)
2.5.3 Global SARS-Cov-2 Vaccine (Vero Cell) Sale Price by Application (2018-2023)
3 GLOBAL SARS-COV-2 VACCINE (VERO CELL) BY COMPANY
3.1 Global SARS-Cov-2 Vaccine (Vero Cell) Breakdown Data by Company
3.1.1 Global SARS-Cov-2 Vaccine (Vero Cell) Annual Sales by Company (2018-2023)
3.1.2 Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Company (2018-2023)
3.2 Global SARS-Cov-2 Vaccine (Vero Cell) Annual Revenue by Company (2018-2023)
3.2.1 Global SARS-Cov-2 Vaccine (Vero Cell) Revenue by Company (2018-2023)
3.2.2 Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Company (2018-2023)
3.3 Global SARS-Cov-2 Vaccine (Vero Cell) Sale Price by Company
3.4 Key Manufacturers SARS-Cov-2 Vaccine (Vero Cell) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers SARS-Cov-2 Vaccine (Vero Cell) Product Location Distribution
3.4.2 Players SARS-Cov-2 Vaccine (Vero Cell) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR SARS-COV-2 VACCINE (VERO CELL) BY GEOGRAPHIC REGION
4.1 World Historic SARS-Cov-2 Vaccine (Vero Cell) Market Size by Geographic Region (2018-2023)
4.1.1 Global SARS-Cov-2 Vaccine (Vero Cell) Annual Sales by Geographic Region (2018-2023)
4.1.2 Global SARS-Cov-2 Vaccine (Vero Cell) Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic SARS-Cov-2 Vaccine (Vero Cell) Market Size by Country/Region (2018-2023)
4.2.1 Global SARS-Cov-2 Vaccine (Vero Cell) Annual Sales by Country/Region (2018-2023)
4.2.2 Global SARS-Cov-2 Vaccine (Vero Cell) Annual Revenue by Country/Region (2018-2023)
4.3 Americas SARS-Cov-2 Vaccine (Vero Cell) Sales Growth
4.4 APAC SARS-Cov-2 Vaccine (Vero Cell) Sales Growth
4.5 Europe SARS-Cov-2 Vaccine (Vero Cell) Sales Growth
4.6 Middle East & Africa SARS-Cov-2 Vaccine (Vero Cell) Sales Growth
5 AMERICAS
5.1 Americas SARS-Cov-2 Vaccine (Vero Cell) Sales by Country
5.1.1 Americas SARS-Cov-2 Vaccine (Vero Cell) Sales by Country (2018-2023)
5.1.2 Americas SARS-Cov-2 Vaccine (Vero Cell) Revenue by Country (2018-2023)
5.2 Americas SARS-Cov-2 Vaccine (Vero Cell) Sales by Type
5.3 Americas SARS-Cov-2 Vaccine (Vero Cell) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC SARS-Cov-2 Vaccine (Vero Cell) Sales by Region
6.1.1 APAC SARS-Cov-2 Vaccine (Vero Cell) Sales by Region (2018-2023)
6.1.2 APAC SARS-Cov-2 Vaccine (Vero Cell) Revenue by Region (2018-2023)
6.2 APAC SARS-Cov-2 Vaccine (Vero Cell) Sales by Type
6.3 APAC SARS-Cov-2 Vaccine (Vero Cell) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe SARS-Cov-2 Vaccine (Vero Cell) by Country
7.1.1 Europe SARS-Cov-2 Vaccine (Vero Cell) Sales by Country (2018-2023)
7.1.2 Europe SARS-Cov-2 Vaccine (Vero Cell) Revenue by Country (2018-2023)
7.2 Europe SARS-Cov-2 Vaccine (Vero Cell) Sales by Type
7.3 Europe SARS-Cov-2 Vaccine (Vero Cell) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa SARS-Cov-2 Vaccine (Vero Cell) by Country
8.1.1 Middle East & Africa SARS-Cov-2 Vaccine (Vero Cell) Sales by Country (2018-2023)
8.1.2 Middle East & Africa SARS-Cov-2 Vaccine (Vero Cell) Revenue by Country (2018-2023)
8.2 Middle East & Africa SARS-Cov-2 Vaccine (Vero Cell) Sales by Type
8.3 Middle East & Africa SARS-Cov-2 Vaccine (Vero Cell) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of SARS-Cov-2 Vaccine (Vero Cell)
10.3 Manufacturing Process Analysis of SARS-Cov-2 Vaccine (Vero Cell)
10.4 Industry Chain Structure of SARS-Cov-2 Vaccine (Vero Cell)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 SARS-Cov-2 Vaccine (Vero Cell) Distributors
11.3 SARS-Cov-2 Vaccine (Vero Cell) Customer
12 WORLD FORECAST REVIEW FOR SARS-COV-2 VACCINE (VERO CELL) BY GEOGRAPHIC REGION
12.1 Global SARS-Cov-2 Vaccine (Vero Cell) Market Size Forecast by Region
12.1.1 Global SARS-Cov-2 Vaccine (Vero Cell) Forecast by Region (2024-2029)
12.1.2 Global SARS-Cov-2 Vaccine (Vero Cell) Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global SARS-Cov-2 Vaccine (Vero Cell) Forecast by Type
12.7 Global SARS-Cov-2 Vaccine (Vero Cell) Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Sinopharm
13.1.1 Sinopharm Company Information
13.1.2 Sinopharm SARS-Cov-2 Vaccine (Vero Cell) Product Portfolios and Specifications
13.1.3 Sinopharm SARS-Cov-2 Vaccine (Vero Cell) Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Sinopharm Main Business Overview
13.1.5 Sinopharm Latest Developments
13.2 Sinovac Biotech
13.2.1 Sinovac Biotech Company Information
13.2.2 Sinovac Biotech SARS-Cov-2 Vaccine (Vero Cell) Product Portfolios and Specifications
13.2.3 Sinovac Biotech SARS-Cov-2 Vaccine (Vero Cell) Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Sinovac Biotech Main Business Overview
13.2.5 Sinovac Biotech Latest Developments
13.3 BIBP
13.3.1 BIBP Company Information
13.3.2 BIBP SARS-Cov-2 Vaccine (Vero Cell) Product Portfolios and Specifications
13.3.3 BIBP SARS-Cov-2 Vaccine (Vero Cell) Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 BIBP Main Business Overview
13.3.5 BIBP Latest Developments
13.4 IMBCAMS,China
13.4.1 IMBCAMS,China Company Information
13.4.2 IMBCAMS,China SARS-Cov-2 Vaccine (Vero Cell) Product Portfolios and Specifications
13.4.3 IMBCAMS,China SARS-Cov-2 Vaccine (Vero Cell) Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 IMBCAMS,China Main Business Overview
13.4.5 IMBCAMS,China Latest Developments
13.5 WIBP
13.5.1 WIBP Company Information
13.5.2 WIBP SARS-Cov-2 Vaccine (Vero Cell) Product Portfolios and Specifications
13.5.3 WIBP SARS-Cov-2 Vaccine (Vero Cell) Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 WIBP Main Business Overview
13.5.5 WIBP Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. SARS-Cov-2 Vaccine (Vero Cell) Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. SARS-Cov-2 Vaccine (Vero Cell) Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Whole Virus Inactivated Vaccine
Table 4. Major Players of Split Vaccine
Table 5. Major Players of Subunit Vaccine
Table 6. Major Players of Others
Table 7. Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Type (2018-2023) & (K Units)
Table 8. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Type (2018-2023)
Table 9. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue by Type (2018-2023) & ($ million)
Table 10. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Type (2018-2023)
Table 11. Global SARS-Cov-2 Vaccine (Vero Cell) Sale Price by Type (2018-2023) & (US$/Unit)
Table 12. Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Application (2018-2023) & (K Units)
Table 13. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Application (2018-2023)
Table 14. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue by Application (2018-2023)
Table 15. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Application (2018-2023)
Table 16. Global SARS-Cov-2 Vaccine (Vero Cell) Sale Price by Application (2018-2023) & (US$/Unit)
Table 17. Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Company (2018-2023) & (K Units)
Table 18. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Company (2018-2023)
Table 19. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue by Company (2018-2023) ($ Millions)
Table 20. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Company (2018-2023)
Table 21. Global SARS-Cov-2 Vaccine (Vero Cell) Sale Price by Company (2018-2023) & (US$/Unit)
Table 22. Key Manufacturers SARS-Cov-2 Vaccine (Vero Cell) Producing Area Distribution and Sales Area
Table 23. Players SARS-Cov-2 Vaccine (Vero Cell) Products Offered
Table 24. SARS-Cov-2 Vaccine (Vero Cell) Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Geographic Region (2018-2023) & (K Units)
Table 28. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share Geographic Region (2018-2023)
Table 29. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Country/Region (2018-2023) & (K Units)
Table 32. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Country/Region (2018-2023)
Table 33. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas SARS-Cov-2 Vaccine (Vero Cell) Sales by Country (2018-2023) & (K Units)
Table 36. Americas SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Country (2018-2023)
Table 37. Americas SARS-Cov-2 Vaccine (Vero Cell) Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Country (2018-2023)
Table 39. Americas SARS-Cov-2 Vaccine (Vero Cell) Sales by Type (2018-2023) & (K Units)
Table 40. Americas SARS-Cov-2 Vaccine (Vero Cell) Sales by Application (2018-2023) & (K Units)
Table 41. APAC SARS-Cov-2 Vaccine (Vero Cell) Sales by Region (2018-2023) & (K Units)
Table 42. APAC SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Region (2018-2023)
Table 43. APAC SARS-Cov-2 Vaccine (Vero Cell) Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Region (2018-2023)
Table 45. APAC SARS-Cov-2 Vaccine (Vero Cell) Sales by Type (2018-2023) & (K Units)
Table 46. APAC SARS-Cov-2 Vaccine (Vero Cell) Sales by Application (2018-2023) & (K Units)
Table 47. Europe SARS-Cov-2 Vaccine (Vero Cell) Sales by Country (2018-2023) & (K Units)
Table 48. Europe SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Country (2018-2023)
Table 49. Europe SARS-Cov-2 Vaccine (Vero Cell) Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Country (2018-2023)
Table 51. Europe SARS-Cov-2 Vaccine (Vero Cell) Sales by Type (2018-2023) & (K Units)
Table 52. Europe SARS-Cov-2 Vaccine (Vero Cell) Sales by Application (2018-2023) & (K Units)
Table 53. Middle East & Africa SARS-Cov-2 Vaccine (Vero Cell) Sales by Country (2018-2023) & (K Units)
Table 54. Middle East & Africa SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa SARS-Cov-2 Vaccine (Vero Cell) Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa SARS-Cov-2 Vaccine (Vero Cell) Sales by Type (2018-2023) & (K Units)
Table 58. Middle East & Africa SARS-Cov-2 Vaccine (Vero Cell) Sales by Application (2018-2023) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of SARS-Cov-2 Vaccine (Vero Cell)
Table 60. Key Market Challenges & Risks of SARS-Cov-2 Vaccine (Vero Cell)
Table 61. Key Industry Trends of SARS-Cov-2 Vaccine (Vero Cell)
Table 62. SARS-Cov-2 Vaccine (Vero Cell) Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. SARS-Cov-2 Vaccine (Vero Cell) Distributors List
Table 65. SARS-Cov-2 Vaccine (Vero Cell) Customer List
Table 66. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Forecast by Region (2024-2029) & (K Units)
Table 67. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas SARS-Cov-2 Vaccine (Vero Cell) Sales Forecast by Country (2024-2029) & (K Units)
Table 69. Americas SARS-Cov-2 Vaccine (Vero Cell) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC SARS-Cov-2 Vaccine (Vero Cell) Sales Forecast by Region (2024-2029) & (K Units)
Table 71. APAC SARS-Cov-2 Vaccine (Vero Cell) Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe SARS-Cov-2 Vaccine (Vero Cell) Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Europe SARS-Cov-2 Vaccine (Vero Cell) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa SARS-Cov-2 Vaccine (Vero Cell) Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Middle East & Africa SARS-Cov-2 Vaccine (Vero Cell) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Forecast by Type (2024-2029) & (K Units)
Table 77. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Forecast by Application (2024-2029) & (K Units)
Table 79. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Sinopharm Basic Information, SARS-Cov-2 Vaccine (Vero Cell) Manufacturing Base, Sales Area and Its Competitors
Table 81. Sinopharm SARS-Cov-2 Vaccine (Vero Cell) Product Portfolios and Specifications
Table 82. Sinopharm SARS-Cov-2 Vaccine (Vero Cell) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Sinopharm Main Business
Table 84. Sinopharm Latest Developments
Table 85. Sinovac Biotech Basic Information, SARS-Cov-2 Vaccine (Vero Cell) Manufacturing Base, Sales Area and Its Competitors
Table 86. Sinovac Biotech SARS-Cov-2 Vaccine (Vero Cell) Product Portfolios and Specifications
Table 87. Sinovac Biotech SARS-Cov-2 Vaccine (Vero Cell) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Sinovac Biotech Main Business
Table 89. Sinovac Biotech Latest Developments
Table 90. BIBP Basic Information, SARS-Cov-2 Vaccine (Vero Cell) Manufacturing Base, Sales Area and Its Competitors
Table 91. BIBP SARS-Cov-2 Vaccine (Vero Cell) Product Portfolios and Specifications
Table 92. BIBP SARS-Cov-2 Vaccine (Vero Cell) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. BIBP Main Business
Table 94. BIBP Latest Developments
Table 95. IMBCAMS,China Basic Information, SARS-Cov-2 Vaccine (Vero Cell) Manufacturing Base, Sales Area and Its Competitors
Table 96. IMBCAMS,China SARS-Cov-2 Vaccine (Vero Cell) Product Portfolios and Specifications
Table 97. IMBCAMS,China SARS-Cov-2 Vaccine (Vero Cell) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. IMBCAMS,China Main Business
Table 99. IMBCAMS,China Latest Developments
Table 100. WIBP Basic Information, SARS-Cov-2 Vaccine (Vero Cell) Manufacturing Base, Sales Area and Its Competitors
Table 101. WIBP SARS-Cov-2 Vaccine (Vero Cell) Product Portfolios and Specifications
Table 102. WIBP SARS-Cov-2 Vaccine (Vero Cell) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. WIBP Main Business
Table 104. WIBP Latest Developments
Table 1. SARS-Cov-2 Vaccine (Vero Cell) Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. SARS-Cov-2 Vaccine (Vero Cell) Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Whole Virus Inactivated Vaccine
Table 4. Major Players of Split Vaccine
Table 5. Major Players of Subunit Vaccine
Table 6. Major Players of Others
Table 7. Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Type (2018-2023) & (K Units)
Table 8. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Type (2018-2023)
Table 9. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue by Type (2018-2023) & ($ million)
Table 10. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Type (2018-2023)
Table 11. Global SARS-Cov-2 Vaccine (Vero Cell) Sale Price by Type (2018-2023) & (US$/Unit)
Table 12. Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Application (2018-2023) & (K Units)
Table 13. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Application (2018-2023)
Table 14. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue by Application (2018-2023)
Table 15. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Application (2018-2023)
Table 16. Global SARS-Cov-2 Vaccine (Vero Cell) Sale Price by Application (2018-2023) & (US$/Unit)
Table 17. Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Company (2018-2023) & (K Units)
Table 18. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Company (2018-2023)
Table 19. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue by Company (2018-2023) ($ Millions)
Table 20. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Company (2018-2023)
Table 21. Global SARS-Cov-2 Vaccine (Vero Cell) Sale Price by Company (2018-2023) & (US$/Unit)
Table 22. Key Manufacturers SARS-Cov-2 Vaccine (Vero Cell) Producing Area Distribution and Sales Area
Table 23. Players SARS-Cov-2 Vaccine (Vero Cell) Products Offered
Table 24. SARS-Cov-2 Vaccine (Vero Cell) Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Geographic Region (2018-2023) & (K Units)
Table 28. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share Geographic Region (2018-2023)
Table 29. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Country/Region (2018-2023) & (K Units)
Table 32. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Country/Region (2018-2023)
Table 33. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas SARS-Cov-2 Vaccine (Vero Cell) Sales by Country (2018-2023) & (K Units)
Table 36. Americas SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Country (2018-2023)
Table 37. Americas SARS-Cov-2 Vaccine (Vero Cell) Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Country (2018-2023)
Table 39. Americas SARS-Cov-2 Vaccine (Vero Cell) Sales by Type (2018-2023) & (K Units)
Table 40. Americas SARS-Cov-2 Vaccine (Vero Cell) Sales by Application (2018-2023) & (K Units)
Table 41. APAC SARS-Cov-2 Vaccine (Vero Cell) Sales by Region (2018-2023) & (K Units)
Table 42. APAC SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Region (2018-2023)
Table 43. APAC SARS-Cov-2 Vaccine (Vero Cell) Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Region (2018-2023)
Table 45. APAC SARS-Cov-2 Vaccine (Vero Cell) Sales by Type (2018-2023) & (K Units)
Table 46. APAC SARS-Cov-2 Vaccine (Vero Cell) Sales by Application (2018-2023) & (K Units)
Table 47. Europe SARS-Cov-2 Vaccine (Vero Cell) Sales by Country (2018-2023) & (K Units)
Table 48. Europe SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Country (2018-2023)
Table 49. Europe SARS-Cov-2 Vaccine (Vero Cell) Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Country (2018-2023)
Table 51. Europe SARS-Cov-2 Vaccine (Vero Cell) Sales by Type (2018-2023) & (K Units)
Table 52. Europe SARS-Cov-2 Vaccine (Vero Cell) Sales by Application (2018-2023) & (K Units)
Table 53. Middle East & Africa SARS-Cov-2 Vaccine (Vero Cell) Sales by Country (2018-2023) & (K Units)
Table 54. Middle East & Africa SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa SARS-Cov-2 Vaccine (Vero Cell) Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa SARS-Cov-2 Vaccine (Vero Cell) Sales by Type (2018-2023) & (K Units)
Table 58. Middle East & Africa SARS-Cov-2 Vaccine (Vero Cell) Sales by Application (2018-2023) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of SARS-Cov-2 Vaccine (Vero Cell)
Table 60. Key Market Challenges & Risks of SARS-Cov-2 Vaccine (Vero Cell)
Table 61. Key Industry Trends of SARS-Cov-2 Vaccine (Vero Cell)
Table 62. SARS-Cov-2 Vaccine (Vero Cell) Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. SARS-Cov-2 Vaccine (Vero Cell) Distributors List
Table 65. SARS-Cov-2 Vaccine (Vero Cell) Customer List
Table 66. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Forecast by Region (2024-2029) & (K Units)
Table 67. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas SARS-Cov-2 Vaccine (Vero Cell) Sales Forecast by Country (2024-2029) & (K Units)
Table 69. Americas SARS-Cov-2 Vaccine (Vero Cell) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC SARS-Cov-2 Vaccine (Vero Cell) Sales Forecast by Region (2024-2029) & (K Units)
Table 71. APAC SARS-Cov-2 Vaccine (Vero Cell) Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe SARS-Cov-2 Vaccine (Vero Cell) Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Europe SARS-Cov-2 Vaccine (Vero Cell) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa SARS-Cov-2 Vaccine (Vero Cell) Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Middle East & Africa SARS-Cov-2 Vaccine (Vero Cell) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Forecast by Type (2024-2029) & (K Units)
Table 77. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Forecast by Application (2024-2029) & (K Units)
Table 79. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Sinopharm Basic Information, SARS-Cov-2 Vaccine (Vero Cell) Manufacturing Base, Sales Area and Its Competitors
Table 81. Sinopharm SARS-Cov-2 Vaccine (Vero Cell) Product Portfolios and Specifications
Table 82. Sinopharm SARS-Cov-2 Vaccine (Vero Cell) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Sinopharm Main Business
Table 84. Sinopharm Latest Developments
Table 85. Sinovac Biotech Basic Information, SARS-Cov-2 Vaccine (Vero Cell) Manufacturing Base, Sales Area and Its Competitors
Table 86. Sinovac Biotech SARS-Cov-2 Vaccine (Vero Cell) Product Portfolios and Specifications
Table 87. Sinovac Biotech SARS-Cov-2 Vaccine (Vero Cell) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Sinovac Biotech Main Business
Table 89. Sinovac Biotech Latest Developments
Table 90. BIBP Basic Information, SARS-Cov-2 Vaccine (Vero Cell) Manufacturing Base, Sales Area and Its Competitors
Table 91. BIBP SARS-Cov-2 Vaccine (Vero Cell) Product Portfolios and Specifications
Table 92. BIBP SARS-Cov-2 Vaccine (Vero Cell) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. BIBP Main Business
Table 94. BIBP Latest Developments
Table 95. IMBCAMS,China Basic Information, SARS-Cov-2 Vaccine (Vero Cell) Manufacturing Base, Sales Area and Its Competitors
Table 96. IMBCAMS,China SARS-Cov-2 Vaccine (Vero Cell) Product Portfolios and Specifications
Table 97. IMBCAMS,China SARS-Cov-2 Vaccine (Vero Cell) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. IMBCAMS,China Main Business
Table 99. IMBCAMS,China Latest Developments
Table 100. WIBP Basic Information, SARS-Cov-2 Vaccine (Vero Cell) Manufacturing Base, Sales Area and Its Competitors
Table 101. WIBP SARS-Cov-2 Vaccine (Vero Cell) Product Portfolios and Specifications
Table 102. WIBP SARS-Cov-2 Vaccine (Vero Cell) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. WIBP Main Business
Table 104. WIBP Latest Developments
LIST OF FIGURES
Figure 1. Picture of SARS-Cov-2 Vaccine (Vero Cell)
Figure 2. SARS-Cov-2 Vaccine (Vero Cell) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. SARS-Cov-2 Vaccine (Vero Cell) Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Whole Virus Inactivated Vaccine
Figure 10. Product Picture of Split Vaccine
Figure 11. Product Picture of Subunit Vaccine
Figure 12. Product Picture of Others
Figure 13. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Type in 2022
Figure 14. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Type (2018-2023)
Figure 15. SARS-Cov-2 Vaccine (Vero Cell) Consumed in Special Population
Figure 16. Global SARS-Cov-2 Vaccine (Vero Cell) Market: Special Population (2018-2023) & (K Units)
Figure 17. SARS-Cov-2 Vaccine (Vero Cell) Consumed in General Population
Figure 18. Global SARS-Cov-2 Vaccine (Vero Cell) Market: General Population (2018-2023) & (K Units)
Figure 19. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Application (2022)
Figure 20. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Application in 2022
Figure 21. SARS-Cov-2 Vaccine (Vero Cell) Sales Market by Company in 2022 (K Units)
Figure 22. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Company in 2022
Figure 23. SARS-Cov-2 Vaccine (Vero Cell) Revenue Market by Company in 2022 ($ Million)
Figure 24. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Company in 2022
Figure 25. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Geographic Region in 2022
Figure 27. Americas SARS-Cov-2 Vaccine (Vero Cell) Sales 2018-2023 (K Units)
Figure 28. Americas SARS-Cov-2 Vaccine (Vero Cell) Revenue 2018-2023 ($ Millions)
Figure 29. APAC SARS-Cov-2 Vaccine (Vero Cell) Sales 2018-2023 (K Units)
Figure 30. APAC SARS-Cov-2 Vaccine (Vero Cell) Revenue 2018-2023 ($ Millions)
Figure 31. Europe SARS-Cov-2 Vaccine (Vero Cell) Sales 2018-2023 (K Units)
Figure 32. Europe SARS-Cov-2 Vaccine (Vero Cell) Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa SARS-Cov-2 Vaccine (Vero Cell) Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa SARS-Cov-2 Vaccine (Vero Cell) Revenue 2018-2023 ($ Millions)
Figure 35. Americas SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Country in 2022
Figure 36. Americas SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Country in 2022
Figure 37. Americas SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Type (2018-2023)
Figure 38. Americas SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Application (2018-2023)
Figure 39. United States SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Region in 2022
Figure 44. APAC SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Regions in 2022
Figure 45. APAC SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Type (2018-2023)
Figure 46. APAC SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Application (2018-2023)
Figure 47. China SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth 2018-2023 ($ Millions)
Figure 51. India SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Country in 2022
Figure 55. Europe SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Country in 2022
Figure 56. Europe SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Type (2018-2023)
Figure 57. Europe SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Application (2018-2023)
Figure 58. Germany SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth 2018-2023 ($ Millions)
Figure 59. France SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Country in 2022
Figure 64. Middle East & Africa SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Application (2018-2023)
Figure 67. Egypt SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of SARS-Cov-2 Vaccine (Vero Cell) in 2022
Figure 73. Manufacturing Process Analysis of SARS-Cov-2 Vaccine (Vero Cell)
Figure 74. Industry Chain Structure of SARS-Cov-2 Vaccine (Vero Cell)
Figure 75. Channels of Distribution
Figure 76. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Forecast by Region (2024-2029)
Figure 77. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of SARS-Cov-2 Vaccine (Vero Cell)
Figure 2. SARS-Cov-2 Vaccine (Vero Cell) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. SARS-Cov-2 Vaccine (Vero Cell) Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Whole Virus Inactivated Vaccine
Figure 10. Product Picture of Split Vaccine
Figure 11. Product Picture of Subunit Vaccine
Figure 12. Product Picture of Others
Figure 13. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Type in 2022
Figure 14. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Type (2018-2023)
Figure 15. SARS-Cov-2 Vaccine (Vero Cell) Consumed in Special Population
Figure 16. Global SARS-Cov-2 Vaccine (Vero Cell) Market: Special Population (2018-2023) & (K Units)
Figure 17. SARS-Cov-2 Vaccine (Vero Cell) Consumed in General Population
Figure 18. Global SARS-Cov-2 Vaccine (Vero Cell) Market: General Population (2018-2023) & (K Units)
Figure 19. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Application (2022)
Figure 20. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Application in 2022
Figure 21. SARS-Cov-2 Vaccine (Vero Cell) Sales Market by Company in 2022 (K Units)
Figure 22. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Company in 2022
Figure 23. SARS-Cov-2 Vaccine (Vero Cell) Revenue Market by Company in 2022 ($ Million)
Figure 24. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Company in 2022
Figure 25. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Geographic Region in 2022
Figure 27. Americas SARS-Cov-2 Vaccine (Vero Cell) Sales 2018-2023 (K Units)
Figure 28. Americas SARS-Cov-2 Vaccine (Vero Cell) Revenue 2018-2023 ($ Millions)
Figure 29. APAC SARS-Cov-2 Vaccine (Vero Cell) Sales 2018-2023 (K Units)
Figure 30. APAC SARS-Cov-2 Vaccine (Vero Cell) Revenue 2018-2023 ($ Millions)
Figure 31. Europe SARS-Cov-2 Vaccine (Vero Cell) Sales 2018-2023 (K Units)
Figure 32. Europe SARS-Cov-2 Vaccine (Vero Cell) Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa SARS-Cov-2 Vaccine (Vero Cell) Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa SARS-Cov-2 Vaccine (Vero Cell) Revenue 2018-2023 ($ Millions)
Figure 35. Americas SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Country in 2022
Figure 36. Americas SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Country in 2022
Figure 37. Americas SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Type (2018-2023)
Figure 38. Americas SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Application (2018-2023)
Figure 39. United States SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Region in 2022
Figure 44. APAC SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Regions in 2022
Figure 45. APAC SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Type (2018-2023)
Figure 46. APAC SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Application (2018-2023)
Figure 47. China SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth 2018-2023 ($ Millions)
Figure 51. India SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Country in 2022
Figure 55. Europe SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Country in 2022
Figure 56. Europe SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Type (2018-2023)
Figure 57. Europe SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Application (2018-2023)
Figure 58. Germany SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth 2018-2023 ($ Millions)
Figure 59. France SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Country in 2022
Figure 64. Middle East & Africa SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Application (2018-2023)
Figure 67. Egypt SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of SARS-Cov-2 Vaccine (Vero Cell) in 2022
Figure 73. Manufacturing Process Analysis of SARS-Cov-2 Vaccine (Vero Cell)
Figure 74. Industry Chain Structure of SARS-Cov-2 Vaccine (Vero Cell)
Figure 75. Channels of Distribution
Figure 76. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Forecast by Region (2024-2029)
Figure 77. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share Forecast by Application (2024-2029)
